Literature DB >> 19293137

Sudden death and associated factors in a historical cohort of chronic haemodialysis patients.

Simonetta Genovesi1, Maria G Valsecchi, Emanuela Rossi, Daniela Pogliani, Irene Acquistapace, Vincenzo De Cristofaro, Andrea Stella, Antonio Vincenti.   

Abstract

BACKGROUND: In haemodialysis patients, deaths due to cardiovascular causes constitute a large proportion of total mortality and sudden cardiac deaths account for approximately 22% of all deaths. The aim of this study was to evaluate the incidence of sudden cardiac death and associated risk factors in a cohort of haemodialysis patients. METHODS AND
RESULTS: The 3-year cumulative incidence of death in a cohort of 476 patients on chronic haemodialysis treatment was 34.3% (SE 2.3). Sudden death had a 6.9% (SE 1.2) cumulative incidence, with 32 events representing 19.2% of all deaths, while cardiovascular not sudden death and noncardiovascular death accounted for a 3-year cumulative incidence of 7.3% (SE 1.2) and 20.1% (SE 1.9), respectively. According to Cox multivariate analysis, significant risk factors for sudden death were the presence of atrial fibrillation, diabetes mellitus, predialytic hyperkalaemia, haemodialysis mode and C-reactive protein level, which were associated with a 2.9 (CI(95%) 1.3-6.4), 3.0 (CI(95%) 1.3-7.2), 2.7 (CI(95%) 1.3-5.8), 4.5 (CI(95%) 1.3-15.5) and 3.3 (CI(95%) 1.2-8.8)-fold increase in the risk of sudden death, respectively. Sudden death was significantly more frequent during the first 24 h of the first short interdialytic interval and during the last 24 h of the long interval, i.e. immediately before and immediately after the first weekly haemodialysis session (P = 0.02).
CONCLUSIONS: Our data show that the incidence of sudden death in haemodialysis patients is high and that atrial fibrillation, diabetes, hyperkalaemia, haemodialysis mode and C-reactive protein play an important role in developing fatal arrhythmia. Further studies will be necessary to define which interventions could be helpful in reducing this cause of mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293137     DOI: 10.1093/ndt/gfp104

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  43 in total

Review 1.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

Review 2.  Sudden cardiac death in end stage renal disease: unlocking the mystery.

Authors:  D Zachariah; P R Kalra; Paul R Roberts
Journal:  J Nephrol       Date:  2014-11-13       Impact factor: 3.902

3.  Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study.

Authors:  Shani Shastri; Navdeep Tangri; Hocine Tighiouart; Gerald J Beck; Panagiotis Vlagopoulos; Daniel Ornt; Garabed Eknoyan; John W Kusek; Charles Herzog; Alfred K Cheung; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

4.  Outcomes after the long interdialytic break: implications for the dialytic prescription.

Authors:  Jennifer E Flythe; Eduardo Lacson
Journal:  Semin Dial       Date:  2012 Jan-Feb       Impact factor: 3.455

Review 5.  Remote ischaemic conditioning-therapeutic opportunities in renal medicine.

Authors:  Lisa E Crowley; Christopher W McIntyre
Journal:  Nat Rev Nephrol       Date:  2013-11-05       Impact factor: 28.314

6.  Acute effect of a peritoneal dialysis exchange on electrolyte concentration and QT interval in uraemic patients.

Authors:  Simonetta Genovesi; Elisa Nava; Chiara Bartolucci; Stefano Severi; Antonio Vincenti; Gina Contaldo; Giada Bigatti; Daniele Ciurlino; Silvio Volmer Bertoli
Journal:  Clin Exp Nephrol       Date:  2019-08-19       Impact factor: 2.801

7.  How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders.

Authors:  Mitja Lainscak
Journal:  Card Fail Rev       Date:  2017-04

8.  Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Francesca Tentori; Jinyao Zhang; Yun Li; Angelo Karaboyas; Peter Kerr; Rajiv Saran; Juergen Bommer; Friedrich Port; Takashi Akiba; Ronald Pisoni; Bruce Robinson
Journal:  Nephrol Dial Transplant       Date:  2012-03-19       Impact factor: 5.992

9.  A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.

Authors:  Steven Fishbane; Martin Ford; Masafumi Fukagawa; Kieran McCafferty; Anjay Rastogi; Bruce Spinowitz; Konstantin Staroselskiy; Konstantin Vishnevskiy; Vera Lisovskaja; Ayman Al-Shurbaji; Nicolas Guzman; Sunil Bhandari
Journal:  J Am Soc Nephrol       Date:  2019-06-14       Impact factor: 10.121

10.  Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.

Authors:  Eduardo Verde; Armando Pérez de Prado; Juan M López-Gómez; Borja Quiroga; Marian Goicoechea; Ana García-Prieto; Esther Torres; Javier Reque; José Luño
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.